Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence

doi:10.3748/wjg.v31.i22.106937

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 22

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2124)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-7) series, Tables (1-4) series.

Item

Count

PDF

HTML

1340

Figures (1-7)

138

Tables (1-4)

Sum=1632

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

109

Download

223

Sum=332

Publishing Process of This Article

Item

Count

Browse

Download

Sum=102

Jun 14, 2025 (publication date) through Jul 12, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Jun 14, 2025; 31(22): 106937
Published online Jun 14, 2025. doi: 10.3748/wjg.v31.i22.106937

Full Size Figure Download Figure

Figure 2 Flowchart of the algorithm. EV: Extracellular vesicle; UAP: Ultrasound Attenuation Parameter; SHAP: SHapley Additive exPlanations; C1: Case 1; C2: Case 2.

Citation: Trifylli EM, Angelakis A, Kriebardis AG, Papadopoulos N, Fortis SP, Pantazatou V, Koskinas J, Kranidioti H, Koustas E, Sarantis P, Manolakopoulos S, Deutsch M. Extracellular vesicles as biomarkers for metabolic dysfunction-associated steatotic liver disease staging using explainable artificial intelligence. World J Gastroenterol 2025; 31(22): 106937
URL: https://www.wjgnet.com/1007-9327/full/v31/i22/106937.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i22.106937